Thinking of Influences of Small Molecules on Neural Stem Cell Neurogenesis

doi:10.3969/j.issn.2095-1396.2017.01.001

Abstract

Abstract: Recently， there is considerable interest in the development of stem cellbased strategies for the treatment of Alzheimer’s disease， one of the neurodegenerative diseases. To date， so-called regenerative approaches have focused mainly on the development of cell transplantation therapies using cells derived from pluripotent embryonic stem cells （ESCs）. Although some exciting preliminary reports have been described in regard of the efficacy of
ESC-derived replacement therapies， explorations involving ex vivo manipulated ESCs are hindered by events of mutation， immune rejection， and ethical controversy. An alternative approach involves direct in vivo modulation of endogenous adult stem cell populations using small molecules. Although many results have been reported， the interaction between neural stem cell and local niche and the specific signal mechanisms of neural stem cell remain to be
elucidated. Here we present the thinking of the chemical approaches to the regulation of neural stem cell biology that are yielding new biological insights and that may potentially lead to innovative new drugs.

Key words: neural stem cells, Alzheimer&, rsquo, s disease, small molecule, regenerative medicine

CLC Number:

R964

ZHANG Li-hang， YIN Ming. Thinking of Influences of Small Molecules on Neural Stem Cell Neurogenesis[J]. Acta Neuropharmacologica, 2017, 7(1): 1-9.

References

[1] Prince Martin, Adelina Comas-Herrera, Martin Knapp, et al. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future [R]. London: Alzheimer’s Disease International (ADI), 2016: 84-104.

[2] De Strooper Bart, Eric Karran. The cellular phase of Alzheimer’s disease [J]. Cell, 2016, 164(4): 603-615.

[3]Jeffrey Cummings, Paul S Aisen, Bruno DuBois, et al. Drug development in Alzheimer’s disease: the path to 2025 [J]. Alzheimer's Research & Therapy, 2016, 8(1): 39.

[4] Shubham Misra, Bikash Medhi. Drug development status for Alzheimer’s disease: present scenario [J]. Neurol Sci, 2013, 34(6): 831–839.

[5] Kevin M Felsenstein, Kate M Candelario, Dennis A Steindler, et al. Regenerative medicine in Alzheimer’s disease [J]. Translational Research, 2014, 163(4): 432-438

[6] John Hardy, Dennis J Selkoe. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics [J]. Science, 2002， 297(5580):353-356.

[7] Maria Laura Giuffrida, Filippo Caraci, Bruno Pignataro, et al. Beta-amyloid monomers are neuroprotective [J]. J Neurosci, 2009, 29(34):10582-10587

[8] Olaf Bergmann, Jonas Frisén. Why adults need new brain cell [J]. Science, 2013, 340(6133): 695-670.

[9] Fiona Doetsch. A niche for adult neural stem cells [J]. Curr Opin Genet Dev, 2003, 13(5): 543-550.

[10] Roland Coras, Florian Siebzehnrubl, Elisabeth Pauli, et al. Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans [J]. Brain, 2010, 133(11):3359-3372.

[11] Claudia Lieberwirth, Pan Yong-liang, Liu Yan, et al. Hippocampal adult neurogenesis: Its regulation and potential role in spatial learning and memory [J]. Brain Research, 2016 1644: 127-140.

[12] Tincer Gizem, Violeta Mashkaryan, Prabesh Bhattarai, et al. Focus: The Aging Brain: Neural stem/progenitor cells in Alzheimer’s disease[J]. J Yale of Biology and Medicine, 2016, 89(1): 23.

[13] Abdel-Salam OME. Stem cell therapy for Alzheimer’s disease [J]. CNS & Neurological Disorders-Drug Targets, 2011, 10(4):459-485.

[14] Chen Qian, Akira Nakajima, Se Hoon Choi, et al. Adult neurogenesis is functionally associated with AD-like neurodegeneration [J]. Neurobiol Dis, 2008, 29(2):316-326.

[15] He N, Jin Wei-lin, Lok Keng Hoe, et al. Amyloid-b1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2 [J]. Cell Death and Disease, 2013, 4(11):e924.

[16] Jin Kun-lin, Alyson L Peel, Xiao ou Mao, et al. Increased hippocampal neurogenesis in Alzheimer’s disease [J]. PNAS 2004, 101(1):343-347.

[17] Iryna Ziabreva, Elaine Perry, Robert Perry, et al. Altered neurogenesis in Alzheimer’s disease [J]. J Psychosom Res, 2006, 61(3):311-316.

[18] Li Bin, Hidenaga Yamamori, Yoshitaka Tatebayashi, et al. Failure of neuronal maturation in Alzheimer disease dentate gyrus [J]. J Neuropathol Exp Neurol, 2008, 67(1):78-84.

[19] Wesley W Chen, Mathew Blurton-Jones. Concise review: can stem cells be used to tread or model Alzheimer’s disease? [J] Stem Cells, 2012, 30(12):2612-2618.

[20] Lee Ji Han, Il-Hoan Oh, Hyun Kook Lim. Stem Cell Therapy: A Prospective Treatment for Alzheimer's Disease [J]. Psychiatry Investigation, 2016, 13(6): 583-589.

[21] Dennis Steindler, Tareck Kadrie, Helen Fillmore, et al. The subepenedymal zone: “brain marrow” [J]. Prog Brain Res, 1996, 108: 349-363.

[22] Reynolds B A, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system [J]. Science, 1992, 255(5052):1707-1710.

[23] Dana Alliance Steindler, Pincus DW. Stem cells and neurogenesis in the adult human brain [J]. Lancet, 2002, 359(9311):1047-1054.

[24] Ivy S Samuels, J Colleen Karlo, Alicia N Faruzzi, et al. Deletion of ERK2 motogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function [J]. J Neurosci, 2008, 28(27):6983-6995.

[25] Zhang Chun-li, Zou Yu-hua, He Wei-min, et al. A role for adult TXL-positive neural stem cells in learning and behavior [J]. Nature, 2008, 451(7181):1004-1007.

[26] Malcolm Maden. Retinoic acid in the development, regeneration and maintenance of the nervous system [J].Nat Rev Neurosci, 2007, 8(10):755–765.

[27] Phedias Diamandis, Jan Wildenhain, Ian D Clarke, et al. Chemical genetics reveals a complex functional ground state of neural stem cells [J].Nat Chem Biol, 2007, 3(5):268–273

[28] Maria Frank-Kamenetsky, Zhang Xiao-yan, Steve Bottega, et al. Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists [J]. J Biol, 2002, 1(2):10.

[29] Heiko Wurdak, Zhu Shou-tian, Kyung Hoon Min, et al. A small molecule accelerates neuronal differentiation in the adult rat [J]. Proc Natl Acad Sci, 2010, 107(38):16542–16547.

[30] Jonathan P Saxe, Wu Hao, Theresa K Kelly, et al. A phenotypic small-molecule screen identifies an orphan ligand-receptor pair that regulates neural stem cell differentiation [J].Chem Biol, 2007, 14(9):1019–1030.

[31] Canudas A M, Di Giorgi-Gerevini V, Iacovelli L, et al. PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors [J]. J Neurosci, 2004, 24(46):10343–10352.

[32] Cheng Lin, Gao Long-fei, Guan Wu-qiang, et al. Direct conversion of astrocytes into neuronal cells by drug cocktail [J]. Cell Research, 2015, 25(11): 1269

[33] Zhang Lei, Yin Jiu-chao, Hana Yeh, et al. Small molecules efficiently reprogram human astroglial cells into functional neurons [J].Cell Stem Cell, 2015, 17(6): 735-747.

[34] Gao Long-fei, Guan Wu-qiang, Wang Min, et al. Direct generation of human neuronal cells from adult astrocytes by small molecules [J]. Stem Cell Reports, 2017, 8(3): 538-547

[35] Carlos P Fitzsimons, Emma van Bodegraven, Marijn Schouten, et al. Epigenetic regulation of adult neural stem cells: implications for Alzheimer’s disease [J]. Molecular Neurodegeneration, 2014, 9(1): 25

[36] Shen Si-ming, Li Jia-dong, Patrizia Casaccia-Bonnefil. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain [J]. J Cell Biol, 2005, 169(4):577–589

[37] Zhang Ling, Li Peng, Tiffany Hsu, et al. Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression [J]. Differentiation, 2011, 81(4): 233-242

[38] Philippe Taupin. Neurogenic drugs and compounds [J]. Recent Pat CNS Drug Discov, 2010, 5(3):253-257.

[39] Ma Jing, Gao Yuan, Jiang Lin, et al. Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice[J]. Oncotarget, 2017, 8(17): 27676.

[40] Mowla A, Mosavinasab M, Pani A. Does fluxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial [J]. J Clin Psychopharmacol, 2007, 27(1):67-70.

[41] Juan Sanchez-Ramos, Cynthia R Cimino, Ross Avila, et al. Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer’s disease [J]. J Alzheimers Dis, 2012, 31(4):843-855.

[42] Keith Wollen. Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners [J]. Altern Med Rev, 2010, 15(3):223-244.

[43] Robert J Williams, Jeremy PE Spencer. Flavonoids, cognition, and dementia: actions, mechanisms and potential therapeutics utility for Alzheimer’s disease [J]. Free Radic Biol, 2012, 52(1):35-45.

[44] Ren Zhi-li, Zuo Ping-ping. Neural regeneration: role of traditional Chinese medicine in neurological diseases treatment [J]. J Pharmacol Sci, 2012, 120(3):139-145.

[45] Florian T Merkle, Zaman Mirzadeh, Arturo Alvarez-Buylla. Mosaic organization of neural stem cells in the adult brain [J]. Science, 2007, 317(5836): 381–384.

[46] Alvarez-Buylla A, Daniel A Lim. For the long run: maintaining germinal niches in the adult brain [J]. Neuron, 2004, 41(5):683–686.

[47] Zhao Chun-mei, Deng Wei, Fred H Gage. Mechanisms and functional implications of adult neurogenesis [J]. Cell, 2008, 132(4): 645–660.

[48] Juan I Castrillo, Stephen G Oliver. Alzheimer’s as a systems-level disease involving the interplay of multiple cellular networks [J]. Systems Biology of Alzheimer's Disease, 2016: 3-48.

[49] Lyssiotis C A, Lairson L L, Boitano A E, et al. Chemical control of stem cell fate and developmental potential [J]. Angew Chem Int Ed Engl, 2011, 50(1):200–242.

[50] Andras J Bauer, Brent Stockwell. Neurobiological applications of small molecule screening [J]. Chem. Rev, 2008, 108(5):1774–1786.

Thinking of Influences of Small Molecules on Neural Stem Cell Neurogenesis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin. Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8.
[2]	SUN Li-cong, ZHANG Dan-shen. Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37.
[3]	WANG Si-yi, LI Xian-xiang, LIU Yi-zhou, DU Shuang, GE Chao, LIU Si-si. Current Situation and Prospect of Alzeimer’s Disease Treatment [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 38-42.
[4]	ZHAO Yu-wei, ZHEN Yan-jie, DAI Yue-ying, SHEN Li-xia. Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 55-64.
[5]	HAI Ji-tao, LUO Huan-min. Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64.
[6]	ZHANG Hao-ting, SONG Gui-qin, CUI Ruo-tong, HAO Min, WANG Wen-dong. Mining Target Genes of Alzheimer’s Disease Associated with Biological Clock by Bioinformatics Analysis [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 1-7.
[7]	YANG Xu-hua, DU Shuang, SHEN Li-xia, HAO Jun-rong. Research Progress in Drug Treatment of Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 47-53.
[8]	ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia. Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46.
[9]	YANG-Lin，AI-Jing. Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease [J]. Acta Neuropharmacologica, 2019, 9(5): 50-64.
[10]	ZHANG Shuai，AI Jing. Glutamate Dysfunction and Alzheimer’s Disease [J]. Acta Neuropharmacologica, 2018, 8(6): 9-20.
[11]	王奇. Bushen-Yizhi Formula Inhibits the NLRP3/NFκB Mediated Neuroinflammation and Improves the Motor Dysfunction in a Mouse Model of Parkinson's Disease [J]. Acta Neuropharmacologica, 2018, 8(5): 71-72.
[12]	CUI Su-ying, SONG Jin-zhi, CUI Xiang-yu, HU Xiao, DING Hui, YE Hui, ZHANG Yong-he. Intracerebroventricular Streptozocin-induced Alzheimer’s Disease-like Sleep Disorders: Role of the GABAergic System in the Parabrachial Complex [J]. Acta Neuropharmacologica, 2018, 8(5): 96-97.
[13]	YU Li-li1，2，XU Li1，WANG Yi-nuo1，XUE Lu-ning1，Gou Ji-wei1，LI Hong-bo1，HOU Xue-qin1，ZHANG Han-ting1. Effects of Osthole on Learning and Memory and the Estrogen Pathway in Ovariectomized Rats [J]. Acta Neuropharmacologica, 2018, 8(4): 7-8.
[14]	SHEN li-xia1，LIU Liang-liang1，ZHANG Ming1，LIU Yang1，ZHANG Dan-shen 2. Research of Quercetin’s Estrogen-Like Action on Central Nervous System and Its Mechanisms* [J]. Acta Neuropharmacologica, 2018, 8(4): 23-25.
[15]	WANG Hao1, ZHANG Fang-fang1, FU Hua-rong1, ZHOU Yan-meng1, LIU Xin1, HOU Xue-qin 1, HU Wei2, Rolf Hansen2, XU Ying3, James O’Donnell3, ZHANG Han-ting1,2. Targeting PDE4 for Alzheimer’s Disease and Alcoholism: An implication in Alcohol-Related Dementia? [J]. Acta Neuropharmacologica, 2018, 8(4): 39-41.